Skip to main content
. 2022 Aug 24;11(9):963. doi: 10.3390/pathogens11090963

Table 8.

General information and characteristics of the candidiasis described for Candida pelliculosa.

Invasive/Non-
invasive Candidiasis
(No. of Human Cases/Strains/Isolates)
Identification
Methods
Antifungal
Susceptibility
Antifungal
Resistance
Antifungal
Treatment
Other Treatments
(e.g., Probiotics, Natural Compounds, Antivirals)
Outcome
(n)
Reference(s)
(invasive)
Candidemia
(n = 1)
Blood culture,
Vitek-2 kit
Fluconazole,
flucytosine caspofungin, voriconazole, and amphotericin B
No Intravenous fluconazole for 2 weeks NA Alive (n = 1) [122]
(noninvasive)
Endophthalmitis
(n = 1)
Culture of anterior chamber Intraocular amphotericin B Topical fluconazole Multiple intraocular
amphotericin B
Netilmicin sulfate cyclopentolate HCl eye drops Alive (n = 1) [135]
(noninvasive)
Dacryocystitis with cacosmia
(n = 1)
fungal hyphae observed on the excised lacrimal sac wall.
DNA sequencing
NR NR Antifungal agent and washing of the nasolacrimal duct NA Alive (n = 1) [136]
(invasive)
Candidemia
(n = 6)
Blood culture, API-32C and Mini API system,
RAPD
2 isolates were resistant to Amphotericin B and low susceptibility to Itraconazole Fluconazole, voriconazole, and micafungin Amphotericin B
and fluconazole
NA Alive (n = 5)
Died (n = 1)
[125]
(invasive)
Candidemia
(n = 1)
Blood culture, VITEC2, (ITS) region amplification and sequencing Amphotericin B, ketoconazole, itraconazole, voriconazole, and fluconazole No Fluconazole and
amphotericin B
Ceftriaxone, cefepime. and oxacillin Alive (n = 1) [137]
(noninvasive)
Fungal keratitis
(n = 1)
Morphological characteristics and ITS region amplification and sequencing NR NR Topical micafungin No Alive (n = 1) [138]
(invasive)
Meningitis in HIV patient caused by C. pelliculosa
(n = 1)
Phenotypic and molecular methods,
Histopathological staining(PAS) from autopsy
NR NR NR Combination antiretroviral therapy
(tenofovir, abacavir and atazanavir/ritonavir)
Died (n = 1) [139]

RAPD: randomly amplified polymorphic DNA; ITS: internal transcribed spacer; NA: not applicable/available; PAS: periodic acid–Schiff.